메디원드 (MDWD) 주가

메디원드(MDWD)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $13.40 (+0.37%), 시가총액 $0.21B, 52주 최저~최고 $15.05 ~ $22.24.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated i

핵심 지표

• 현재가: $13.40 (+0.37%)
• 시가총액: $0.21B
• 52주 최저~최고: $15.05 ~ $22.24
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NASDAQ

메디원드의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

메디원드 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.6667

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 4.88
• 순이익률: -1.41%
• 영업이익률: -4.18%

자주 묻는 질문